High-dose corticosteroid therapy in COVID-19: the RECOVERY trial
- PMID: 38582559
- DOI: 10.1016/S0140-6736(23)02882-9
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial
Comment in
-
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.Lancet. 2024 Apr 6;403(10434):1339-1340. doi: 10.1016/S0140-6736(23)02879-9. Lancet. 2024. PMID: 38582564 No abstract available.
Comment on
-
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.Lancet. 2023 May 6;401(10387):1499-1507. doi: 10.1016/S0140-6736(23)00510-X. Epub 2023 Apr 13. Lancet. 2023. PMID: 37060915 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical